Francis Ayuketang A.
- Country
- Germany
- Department
- Onkologisches Zentrum Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation
Research Overview
- Evaluation of MB-CART2019.1 in Patients with Refractory Multiple Sclerosis: A Clinical Trial
- Long-Term Safety Evaluation of KYV-101 in Patients with Lupus Nephritis, Systemic Sclerosis, Myasthenia Gravis, Rheumatoid Arthritis, or Stiff Person Syndrome
- Phase 3 Randomized Open‑Label Study of KITE‑753 Versus Axicabtagene Ciloleucel in Relapsed or Refractory Large B‑Cell Lymphoma After First‑Line Therapy
Data & Insights
Has run more than one trial at 71 of 145 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating advanced blood cancers, with particular focus on multiple myeloma and B-cell non-Hodgkin lymphoma. Their research encompasses innovative cellular therapy approaches for patients with relapsed and refractory conditions.
- CAR-T Cell Therapy Applications
- Multiple Myeloma Treatment
- B-cell Lymphoma Management
Their work includes evaluation of novel BCMA-directed and CD19-directed cellular therapies.
Autoimmune Disorders
The investigator conducts research in advanced therapeutic approaches for progressive multiple sclerosis, exploring innovative cellular therapy solutions for both primary and secondary progressive forms of the disease.
- Multiple Sclerosis Treatment
- CAR-T Applications in Autoimmune Conditions
- Progressive Disease Management
Their work focuses on developing targeted cellular therapies for neurological autoimmune conditions.
Transplant Medicine
The investigator studies therapeutic interventions for acute graft versus host disease, with particular attention to gastrointestinal manifestations and steroid-refractory cases.
- GVHD Management
- Transplant Complications
- Novel Therapeutic Approaches
Their research includes evaluation of innovative treatments for transplant-related complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.